A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection
Clinical trial NCT00002086 · COMPLETED
Trial details
- NCT number
- NCT00002086
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.